antiobesity

antiobesity

(ˌæntɪəʊˈbiːsɪtɪ)
adj
1. reducing or controlling obesity
2. acting against obesity
References in periodicals archive ?
This included [yen]11,859 million from Lenvima, [yen]10,227 million from anticancer agent Halaven, [yen]4,541 million from Fycompa, and [yen]989 million from antiobesity agent BELVIQ.
This, coupled with sparse data on the outcomes of surgical interventions in the Association of Southeast Asian Nations countries, provides generic drugmakers of antiobesity drugs with ample opportunities,' it added.
Attempts at treatment through antiobesity drugs are hampered by their side effects.
The latest stage of his epic antiobesity drive has seen him call for the Government to impose a 9pm watershed on junk food adverts.
Antiobesity medication can be considered if a patient has a body mass index (BMI) [greater than or equal to]30 kg/[m.sup.2] or [greater than or equal to]27 kg/[m.sup.2] with obesity-related comorbidities such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea.
"It will also help our antiobesity drive here in Walsall.
Although nearly half of obesity patients meet BMI eligibility criteria for antiobesity drugs, it is estimated that [less than or equal to] 3.5% receive prescriptions for these drugs in the US (4-6).
Additionally, nitrate has been shown to induce antiobesity effects, including weight loss and reductions in body fat, via increases in the expression of thermogenic genes in brown adipose tissue [9].
Additionally, these compounds also influence lipid metabolism as follows: hesperidin improves lipid metabolism against alcohol injury by reducing endoplasmic reticulum stress and DNA damage [98] and exhibits an antiobesity effect [99]; naringin also influences the lipid profile and ameliorates obesity [100], and finally, baicalein regulates early adipogenesis by inhibiting lipid accumulation and m-TOR signaling [101].
Antiobesity medication can be considered if a patient has a body mass index (BMI) [greater than or equal to] 30 kg/[m.sup.2] or [greater than or equal to] 27 kg/[m.sup.2] with obesity-related comorbidities such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea.
A similar potential association was also reported for antiobesity drugs sibutramine and orlistat (6).
He said the balloon could also provide an alternative to antiobesity drugs and may be useful for people who have found that drugs do not work.